Toll-like receptor 4 promoter polymorphisms: Common TLR4 variants may protect against severe urinary tract infection

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Ragnarsdóttir, Bryndís ^a   Jönsson, Klas ^b   Urbano, Alexander ^b   Grönberg Hernandez, Jenny ^c   Lutay, Nataliya ^a   Tammi, Martti ^d   Gustafsson, Mattias ^a,h   Lundstedt, Ann Charlotte ^a   Leijonhufvud, Irene ^a,h   Karpman, Diana ^e   Wullt, Björn ^c   Truedsson, Lennart ^a   Jodal, Ulf ^f   Andersson, Björn ^g   Svanborg, Catharina ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b AGENCY FOR SCIENCE   (Singapore)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e LUND UNIVERSITY   (Sweden)

^f QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^g KAROLINSKA INSTITUTE   (Sweden)

^h LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 4; TLR4 PROTEIN, HUMAN;

ACUTE PYELONEPHRITIS; ADOLESCENT; ADULT; ARTICLE; BACTERIURIA; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; ESCHERICHIA COLI; ESCHERICHIA COLI 83972; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; INFANT; INNATE IMMUNITY; MALE; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; URINARY TRACT INFECTION; FOLLOW UP; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; GENETICS; PATHOLOGY; PROMOTER REGION; SWEDEN;

ESCHERICHIA COLI;

ADOLESCENT; BACTERIURIA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; IMMUNITY, INNATE; INFANT; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SWEDEN; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION, GENETIC; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 77956561398     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010734     Document Type: Article

References (57)

1. Poltorak A, He X, Smirnova I, Liu MY, Huffel CV, et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085.
2. Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5: 987-995.
3. Uematsu S, Akira S (2006) Toll-like receptors and innate immunity. J Mol Med 84: 712-725.
4. Jin MS, Lee JO (2008) Structures of the toll-like receptor family and its ligand complexes. Immunity 29: 182-191.
5. O'Neill LA, Bowie AG (2007) The family of five: TIR-domaincontaining adaptors in Toll-like receptor signalling. Nat Rev Immunol 7: 353-364.
6. Palsson-McDermott EM, O'Neill LA (2007) Building an immune system from nine domains. Biochem Soc Trans 35: 1437-1444.
7. Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, et al. (2001) Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413: 78-83.
8. Fitzgerald KA, Rowe DC, Barnes BJ, Caffrey DR, Visintin A, et al. (2003) LPSTLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J Exp Med 198: 1043-1055.
9. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, et al. (2003) Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301: 640-643.
10. Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, et al. (2002) Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 169: 6668-6672.
11. Fischer H, Yamamoto M, Akira S, Beutler B, Svanborg C (2006) Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection. Eur J Immunol 36: 267-277.
12. Li X, Qin J (2005) Modulation of Toll-interleukin 1 receptor mediated signaling. J Mol Med 83: 258-266.
13. Smirnova I, Hamblin MT, McBride C, Beutler B, Di Rienzo A (2001) Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans. Genetics 158: 1657-1664.
14. Kunin C (1997) Urinary Tract Infections. Detection, Prevention and Management. Baltimore: Williams and Wilkins.
15. Frendeus B, Godaly G, Hang L, Karpman D, Lundstedt AC, et al. (2000) Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart. J Exp Med 192: 881-890.
16. Lundstedt AC, Leijonhufvud I, Ragnarsdottir B, Karpman D, Andersson B, et al. (2007) Inherited susceptibility to acute pyelonephritis: a family study of urinary tract infection. J Infect Dis 195: 1227-1234.
17. Lundstedt AC, McCarthy S, Gustafsson MC, Godaly G, Jodal U, et al. (2007) A genetic basis of susceptibility to acute pyelonephritis. PLoS ONE 2: e825.
18. Wullt B, Bergsten G, Connell H, Rollano P, Gebretsadik N, et al. (2000) P fimbriae enhance the early establishment of Escherichia coli in the human urinary tract. Mol Microbiol 38: 456-464.
19. Hagberg L, Hull R, Hull S, McGhee JR, Michalek SM, et al. (1984) Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun 46: 839-844.
20. Frendeus B, Wachtler C, Hedlund M, Fischer H, Samuelsson P, et al. (2001) Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation. Mol Microbiol 40: 37-51.
21. Samuelsson P, Hang L, Wullt B, Irjala H, Svanborg C (2004) Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infect Immun 72: 3179-3186.
22. Ragnarsdottir B, Samuelsson M, Gustafsson MC, Leijonhufvud I, Karpman D, et al. (2007) Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria. J Infect Dis 196: 475-484.
23. Martinell J, Claesson I, Lidin-Janson G, Jodal U (1995) Urinary infection, reflux and renal scarring in females continuously followed for 13-38 years. Pediatr Nephrol 9: 131-136.
24. Wullt B, Connell H, Röllano P, Ma°nsson W, Colleen S, et al. (1997) Urodynamic factors influence the persistence of Escherichia coli bacteruria in deliberately colonized patients. J Urology 159: 2057-2062.
25. Wullt B, Bergsten G, Samuelsson M, Gebretsadik N, Hull R, et al. (2001) The role of P fimbriae for colonization and host response induction in the human urinary tract. J Infect Dis 183 Suppl 1: S43-46.
26. Bergsten G, Samuelsson M, Wullt B, Leijonhufvud I, Fischer H, et al. (2004) PapG-dependent adherence breaks mucosal inertia and triggers the innate host response. J Infect Dis 189: 1734-1742.
27. Bergsten G, Wullt B, Schembri MA, Leijonhufvud I, Svanborg C (2007) Do type 1 fimbriae promote inflammation in the human urinary tract? Cell Microbiol 9: 1766-1781.
28. Nickerson DA, Tobe VO, Taylor SL (1997) PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescencebased resequencing. Nucleic Acids Res 25: 2745-2751.
29. Gordon D, Abajian C, Green P (1998) Consed: a graphical tool for sequence finishing. Genome Res 8: 195-202.
30. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, et al. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402.
31. Gollapudi R, Revanna KV, Hemmerich C, Schaack S, Dong Q (2008) BOV-a web-based BLAST output visualization tool. BMC Genomics 9: 414.
32. De Staercke C, Lally C, Austin H, Winston C, Dowling N, et al. (2007) The lack of association between four point mutations in the promoter region of the tolllike 4 receptor gene and myocardial infarction. Thromb Res 119: 105-110.
33. Wegner M, Drolet DW, Rosenfeld MG (1993) Regulation of JC virus by the POU-domain transcription factor Tst-1: implications for progressive multifocal leukoencephalopathy. Proc Natl Acad Sci U S A 90: 4743-4747.
34. Mably JD, Liew CC (1996) Factors involved in cardiogenesis and the regulation of cardiac-specific gene expression. Circ Res 79: 4-13.
35. Matsushita A, Sasaki S, Kashiwabara Y, Nagayama K, Ohba K, et al. (2007) Essential role of GATA2 in the negative regulation of thyrotropin beta gene by thyroid hormone and its receptors. Mol Endocrinol 21: 865-884.
36. Rehli M, Poltorak A, Schwarzfischer L, Krause SW, Andreesen R, et al. (2000) PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene. J Biol Chem 275: 9773-9781.
37. Lichtinger M, Ingram R, Hornef M, Bonifer C, Rehli M (2007) Transcription factor PU.1 controls transcription start site positioning and alternative TLR4 promoter usage. J Biol Chem 282: 26874-26883.
38. Michel O, LeVan TD, Stern D, Dentener M, Thorn J, et al. (2003) Systemic responsiveness to lipopolysaccharide and polymorphisms in the toll-like receptor 4 gene in human beings. J Allergy Clin Immunol 112: 923-929.
39. Svanborg C, Bergsten G, Fischer H, Godaly G, Gustafsson M, et al. (2006) Uropathogenic Escherichia coli as a model of host-parasite interaction. Curr Opin Microbiol 9: 33-39.
40. Bergsten G, Wullt B, Svanborg C (2005) Escherichia coli, fimbriae, bacterial persistence and host response induction in the human urinary tract. Int J Med Microbiol 295: 487-502.
41. Leffler H, Svanborg-Edén C (1980) Chemical identification of a glycosphingolipid receptor for Escherichia coli attaching to human urinary tract epithelial cells and agglutinating human erythrocytes. FEMS Microbiol Lett 8: 127-134.
42. Hedlund M, Svensson M, Nilsson A, Duan RD, Svanborg C (1996) Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli. J Exp Med 183: 1037-1044.
43. Fischer H, Ellstrom P, Ekstrom K, Gustafsson L, Gustafsson M, et al. (2007) Ceramide as a TLR4 agonist; a putative signalling intermediate between sphingolipid receptors for microbial ligands and TLR4. Cell Microbiol.
44. Ransley P, Risdon R (1978) Reflux and renal scarring. Br J Radiol Suppl 14: 1-38.
45. Foxman B, Frerichs RR (1985) Epidemiology of urinary tract infection: II. Diet, clothing, and urination habits. Am J Public Health 75: 1314-1317.
46. Lomberg H, Hanson LA, Jacobsson B, Jodal U, Leffler H, et al. (1983) Correlation of P blood group, vesicoureteral reflux, and bacterial attachment in patients with recurrent pyelonephritis. N Engl J Med 308: 1189-1192.
47. Stapleton A, Nudelman E, Clausen H, Hakomori S, Stamm WE (1992) Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status. J Clin Invest 90: 965-972.
48. Svensson M, Irjala H, Svanborg C, Godaly G (2008) Effects of epithelial and neutrophil CXCR2 on innate immunity and resistance to kidney infection. Kidney Int 74: 81-90.
49. Svanborg Eden C, Briles D, Hagberg L, McGhee J, Michalec S (1984) Genetic factors in host resistance to urinary tract infection. Infection 12: 118-123.
50. Frendeus B, Godaly G, Hang L, Karpman D, Svanborg C (2001) Interleukin-8 receptor deficiency confers susceptibility to acute pyelonephritis. J Infect Dis 183 Suppl 1: S56-60.
51. Karoly E, Fekete A, Banki NF, Szebeni B, Vannay A, et al. (2007) Heat shock protein 72 (HSPA1B) gene polymorphism and Toll-like receptor (TLR) 4 mutation are associated with increased risk of urinary tract infection in children. Pediatr Res 61: 371-374.
52. Hawn TR, Scholes D, Li SS, Wang H, Yang Y, et al. (2009) Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS One 4: e5990.
53. Hawn TR, Scholes D, Wang H, Li SS, Stapleton AE, et al. (2009) Genetic variation of the human urinary tract innate immune response and asymptomatic bacteriuria in women. PLoS One 4: e8300.
54. Nicolle LE (1994) Urinary tract infection in the elderly. J Antimicrob Chemother 33 Suppl A: 99-109.
55. Kiningham RB (1993) Asymptomatic bacteriuria in pregnancy. Am Fam Physician 47: 1232-1238.
56. Ingberg CM, Palmer M, Schvarcz E, Aman J (1998) Prevalence of urinary tract symptoms in long-standing type 1 diabetes mellitus. Diabetes Metab 24: 351-354.
57. Lindberg U, Claesson I, Hanson LA, Jodal U (1978) Asymptomatic bacteriuria in schoolgirls. VIII. Clinical course during a 3-year follow-up. J Pediatr 92: 194-199.